Commensal bacteria in the gut: Learning who our friends are

Current Opinion in Gastroenterology

Volumn 20, Issue 6, 2004, Pages 565-571

  Yan, Fang ^a   Polk, D Brent ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Development; Inflammatory bowel disease; Intestinal epithelial cell; Pathogenesis; Probiotic

Indexed keywords

PROBIOTIC AGENT;

ARTHRITIS; ATOPY; AUTOIMMUNE DISEASE; CARCINOGENESIS; CELIAC DISEASE; CELL FUNCTION; CLINICAL TRIAL; COLON CANCER; DIABETES MELLITUS; DIARRHEA; DISEASE ASSOCIATION; DISEASE COURSE; ENTEROPATHY; GASTROINTESTINAL DISEASE; HELICOBACTER INFECTION; HOMEOSTASIS; HUMAN; IMMUNE RESPONSE; INTESTINE EPITHELIUM CELL; NONHUMAN; PROPHYLAXIS; REVIEW; SEPSIS;

EID: 7444244435     PISSN: 02671379     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001574-200411000-00011     Document Type: Review

References (70)

1. Hooper LV, Wong MH, Thelin A, et al.: Molecular analysis of commensal host-microbial relationships in the intestine. Science 2001, 291:881-884.
2. Nanthakumar NN, Dai D, Newburg DS, Walker WA: The role of indigenous microflora in the development of murine intestinal fucosyl- and sialyltransferases. FASEB J 2003, 17:44-46 (Epub 2002 Nov 15). This interesting study shows that bacterial colonization can stimulate maturational changes in gut glycosyltransferase activities.
3. Stappenbeck TS, Hooper LV, Gordon JI: Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 2002, 99:15451-15455.
4. Xu J, Bjursell MK, Himrod J, et al.: A genomic view of the human-Bacteroides thetaiotaomicron symbiosis. Science 2003, 299:2074-2076. Sequencing of a commensal bacterial genome reveals potential molecular mechanisms supporting the symbiotic relationship with the host.
5. Freitas M, Axelsson LG, Cayuela C, et al.: Microbial-host interactions specifically control the glycosylation pattern in intestinal mouse mucosa. Histochem Cell Biol 2002, 118:149-161 (Epub 2002 Jun 27).
6. Heikkila MP, Saris PE: Inhibition of Staphylococcus aureus by the commensal bacteria of human milk. J Appl Microbiol 2003, 95:471-478.
7. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI: Angiogenins: a new class of microbicidal proteins involved in innate immunity. Nat Immunol 2003, 4:269-273. This elegant study shows Paneth cell induction of an angiogenic factor, with antimicrobial activity, by B. thetaiotaomicron.
8. Ayabe T, Satchell DP, Pesendorfer P, et al.: Activation of Paneth cell α-defensins in mouse small intestine. J Biol Chem 2002, 277:5219-5228 (Epub 2001 Dec 3).
9. Pena JA, Versalovic J: Lactobacillus rhamnosus GG decreases TNF-α production in lipopolysaccharide-activated murine macrophages by a contact-independent mechanism. Cell Microbiol 2003, 5:277-285. This study shows LGG or conditioned media from this probiotic reduce TNF production by macrophages suggesting an additional mechanism of commensal bacteria immunomodulatory activity.
10. Haller D, Serrant P, Peruisseau G, et al.: IL-10 producing CD14low monocytes inhibit lymphocyte-dependent activation of intestinal epithelial cells by commensal bacteria. Microbiol Immunol 2002, 46:195-205.
11. Carlo E, Brown D, McKee M, et al.: Commensal-associated molecular patterns induce selective toll-like receptor-trafficking from apical membrane to cytoplasmic compartments in polarized intestinal epithelium. Am J Pathol 2002, 160:165-173.
12. Smits HH, van Beelen AJ, Hessle C, et al.: Commensal Gram-negative bacteria prime human dendritic cells for enhanced IL-23 and IL-27 expression and enhanced Th1 development. Eur J Immunol 2004, 34:1371-1380. Together with [13••], this study suggests Gram-negative bacteria promote dendritic cell induction of a Th1 inflammatory response.
13. Karlsson H, Larsson P, Wold AE, Rudin A: Pattern of cytokine responses to gram-positive and gram-negative commensal bacteria is profoundly changed when monocytes differentiate into dendritic cells. Infect Immun 2004, 72:2671-2678. The differentiation of monocytes to dendritic cells is associated with loss of responsiveness to Gram-positive bacteria and selective induction of a Th1 response to Gram-negative bacteria.
14. Braat H, de Jong EC, van den Brande JM, et al.: Dichotomy between Lactobacillus rhamnosus and Klebsiella pneumoniae on dendritic cell phenotype and function. J Mol Med 2004, 82:197-205 (Epub 2003 Dec 13).
15. Becker C, Wirtz S, Blessing M, et al.: Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. J Clin Invest 2003, 112:693-706. Dendritic cells in the mouse terminal ileum express constitutive IL-12 p40 and IL-23 that is dependent upon the presence of commensal bacteria. The authors suggest this may explain the predisposition of Crohn disease to occur in the terminal ileum.
16. Drakes M, Blanchard T, Czinn S: Bacterial probiotic modulation of dendritic cells. Infect Immun 2004, 72:3299-3309.
17. Macpherson AJ, Uhr T: Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science 2004, 303:1662-1665. An important study that shows persistence of live commensal bacteria in dendritic cells regulating local IgA production that provides another mechanism to permit commensal bacteria to escape induction of a significant immune response.
18. Resta-Lenert S, Barrett KE: Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003, 52:988-997. Probiotic bacteria can prevent pathogenic bacteria-induced disruption of intestinal epithelial cell tight junctions.
19. Otte JM, Podolsky DK: Functional modulation of enterocytes by gram-positive and gram-negative microorganisms. Am J Physiol Gastrointest Liver Physiol 2004, 286:G613-G626. Probiotic bacterial-derived proteins protect intestinal epithelial cell tight junction integrity.
20. Ankur S, Yan F, Rao RK, Polk DB: Probiotic Lactobacillus GG Secretory Factors Ameliorate Hydrogen Peroxide-Induced Disruption of Intestinal Epithelial Tight Junctions. Gastroenterology 2004, 126(suppl 2):A515.
21. Yan F, Polk DB: Probiotic bacterium prevents cytokine-induced apoptosis in intestinal epithelial cells. J Biol Chem 2002, 277:50959-50965.
22. Mack DR, Ahrne S, Hyde L, et al.: Extracellular MUC3 mucin secretion follows adherence of Lactobacillus strains to intestinal epithelial cells in vitro. Gut 2003, 52:827-833. Probiotic bacteria induce epithelial cell mucin expression.
23. Neish AS: Bacterial inhibition of eukaryotic pro-inflammatory pathways. Immunol Res 2004, 29:175-186.
24. Collier-Hyams LS, Zeng H, Sun J, et al.: Cutting edge: Salmonella AvrA effector inhibits the key proinflammatory, anti-apoptotic NF-κB pathway. J Immunol 2002, 169:2846-2850.
25. Kelly D, Campbell JI, King TP, et al.: Commensal anaerobic gut bacteria attenuate inflammation by regulating nuclear-cytoplasmic shuttling of PPAR-γ and RelA. Nat Immunol 2004, 5:104-112 (Epub 2003 Dec 21). A novel report of bacterial inhibition of NF-κB activation mediated through PPAR-γ.
26. Dubuquoy L, Jansson EA, Deeb S, et al.: Impaired expression of peroxisome proliferator-activated receptor γ in ulcerative colitis. Gastroenterology 2003, 124:1265-1276. Commensal bacterial flora induce PPAR-γ expression in an NF-κB-dependent manner and this expression is reduced in ulcerative colitis.
27. Katayama K, Wada K, Nakajima A, et al.: A novel PPAR γ gene therapy to control inflammation associated with inflammatory bowel disease in a murine model. Gastroenterology 2003, 124:1315-1324.
28. Krieg AM: CpG motifs: the active ingredient in bacterial extracts? Nat Med 2003, 9:831-835. Forced expression of PPAR-γ shows a therapeutic advantage in the DSS colitis model.
29. Jijon H, Backer J, Diaz H, et al.: DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 2004, 126:1358-1373. This report shows DNA from probiotic bacteria reduces the inflammatory response in the IL-10 model of colitis.
30. Rachmilewitz D, Katakura K, Karmeli F, et al.: Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 2004, 126:520-528. A specific oligonucleotide CpG sequence from probiotic DNA attenuates DSS colitis and this protective effect requires host TLR9 expression.
31. Sartor RB: Therapeutic manipulation of the enteric microflora in inflammatory bowel diseases: Antibiotics, probiotics, and prebiotics. Gastroenterology 2004, 126:1620-1633.
32. Hata K, Andoh A, Sato H, et al.: Sequential changes in luminal microflora and mucosal cytokine expression during developing of colitis in HLA-B27/beta2-microglobulin transgenic rats. Scand J Gastroenterol 2001, 36:1185-1192.
33. -/- mouse model of colitis, indicating different commensal bacteria may be involved in region-specific inflammation.
34. Dieleman LA, Hoentjen F, Qian BF, et al.: Reduced ratio of protective versus proinflammatory cytokine responses to commensal bacteria in HLA-B27 transgenic rats. Clin Exp Immunol 2004, 136:30-39.
35. Fellermann K, Wehkamp J, Herrlinger KR, Stange EF: Crohn's disease: a defensin deficiency syndrome? Eur J Gastroenterol Hepatol 2003, 15:627-634.
36. Wehkamp J, Fellermann K, Herrlinger KR, et al.: Human β-defensin 2 but not β-defensin 1 is expressed preferentially in colonic mucosa of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002, 14:745-752.
37. Wehkamp J, Harder J, Weichenthal M, et al.: Inducible and constitutive β-defensins are differentially expressed in Crohn's disease and ulcerative colitis. Inflamm Bowel Dis 2003, 9:215-223.
38. Guarner F, Malagelada JR: Gut flora in health and disease. Lancet 2003, 361:512-519.
39. Heavey PM, Rowland IR: Microbial-gut interactions in health and disease. Gastrointestinal cancer. Best Pract Res Clin Gastroenterol 2004, 18:323-336.
40. Huycke MM, Abrams V, Moore DR: Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 2002, 23:529-536.
41. Chu F-F, Esworthy RS, Chu PG, et al.: Bacteria-induced intestinal cancer in mice with disrupted Gpx1 and Gpx2 genes. Cancer Res 2004, 64:962-968. In mice lacking the primary intestinal glutathione peroxidase enzymes, induction of either ileocolitis or cancer in the ileum or colon requires the presence of commensal bacteria.
42. Isolauri E, Kirjavainen PV, Salminen S: Probiotics: a role in the treatment of intestinal infection and inflammation? Gut 2002, 50(suppl 3):III54-III59.
43. Cremonini F, Di Caro S, Nista EC, et al.: Meta-analysis: the effect of probiotic administration on antibiotic-associated diarrhoea. Aliment Pharmacol Ther 2002, 16:1461-1467.
44. Huang JS, Bousvaros A, Lee JW, et al.: Efficacy of probiotic use in acute diarrhea in children: a meta-analysis. Dig Dis Sci 2002, 47:2625-2634.
45. Van Niel CW, Feudtner C, Garrison MM, Christakis DA: Lactobacillus therapy for acute infectious diarrhea in children: a meta-analysis. Pediatrics 2002, 109:678-684.
46. Plummer S, Weaver MA, Harris JC, et al.: Clostridium difficile pilot study: effects of probiotic supplementation on the incidence of C. difficile diarrhoea. Int Microbiol 2004, 7:59-62.
47. Gionchetti P, Rizzello F, Helwig U, et al.: Prophylaxis of pouchitis onset with probiotic therapy: a double-blind, placebo-controlled trial. Gastroenterology 2003, 124:1202-1209. Treatment of patients with a probiotic bacterial mixture prevents pouchitis following ileo-anal pouch surgery for ulcerative colitis.
48. Mimura T, Rizzello F, Helwig U, et al.: Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut 2004, 53:108-114.
49. Guslandi M, Giollo P, Testoni PA: A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 2003, 15:697-698.
50. Schultz M, Timmer A, Herfarth HH, et al.: Lactobacillus GG in inducing and maintaining remission of Crohn's disease. BMC Gastroenterol 2004, 4:5.
51. Borody TJ, Warren EF, Leis S, et al.: Treatment of ulcerative colitis using fecal bacteriotherapy. J Clin Gastroenterol 2003, 37:42-47. Colonic infusion of human intestinal fecal flora is associated with reversal of ulcerative colitis.
52. Dieleman LA, Goerres MS, Arends A, et al.: Lactobacillus GG prevents recurrence of colitis in HLA-B27 transgenic rats after antibiotic treatment. Gut 2003, 52:370-376. Repopulation of the gastrointestinal tract with a probiotic bacterium prevents recurrence of colitis in the HLA-B27 rat model.
53. Shiba T, Aiba Y, Ishikawa H, et al.: The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. Microbiol Immunol 2003, 47:371-378.
54. Menard S, Candalh C, Bambou JC, et al.: Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut 2004, 53:821-828. Conditioned media from probiotic or commensal bacteria attenuate the inflammatory response to LPS in vivo.
55. Benn CS, Melbye M, Wohlfahrt J, et al.: Cohort study of sibling effect, infectious diseases, and risk of atopic dermatitis during first 18 months of life. BMJ 2004, 328:1223 (Epub 2004 Apr 30).
56. Kalliomaki M, Satminen S, Poussa T, et al.: Probiotics and prevention of atopic disease: 4-year follow-up of a randomised placebo-controlled trial. Lancet 2003, 361:1869-1871. This follow-up study shows sustained reduction in atopic dermatitis among children given a probiotic bacterium during the neonatal period.
57. Rosenfeldt V, Benfeldt E, Nielsen SD, et al.: Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J Allergy Clin Immunol 2003, 111:389-395.
58. Di Cagno R, De Angelis M, Auricchio S, et al.: Sourdough bread made from wheat and nontoxic flours and started with selected lactobacilli is tolerated in celiac sprue patients. Appl Environ Microbiol 2004, 70:1088-1096. Lactobacilli producing peptidases capable of hydrolyzing Pro-rich peptides used in long fermentation sourdough breads may reduce the intestinal injury from gluten in celiac disease patients.
59. Bengmark S: Use of some pre-, pro- and synbiotics in critically ill patients. Best Pract Res Clin Gastroenterol 2003, 17:833-848.
60. Liu Q, Duan ZP, Hada K, et al.: Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004, 39:1441-1449.
61. Shan L, Molberg O, Parrot I, et al.: Structural basis for gluten intolerance in celiac sprue. Science 2002, 297:2275-2279.
62. Dionisi S, Bonato V, Dotta F, et al.: Oral administration of probiotic compound VSL#3 prevents the onset of diabetes in NOD mice. Mucosal Immunology Update 2002, 10:2732.
63. Sheil B, McCarthy J, O'Mahony L, et al.: Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritis. Gut 2004, 53:694-700.
64. Lorca GL, Wadstrom T, Valdez GF, Ljungh A: Lactobacillus acidophilus autolysins inhibit Helicobacter pylori in vitro. Curr Microbiol 2001, 42:39-44.
65. Chatterjee A, Yasmin T, Bagchi D, Stohs SJ: The bactericidal effects of Lactobacillus acidophilus, garcinol and Protykin compared to clarithromycin, on Helicobacter pylori. Mol Cell Biochem 2003, 243:29-35.
66. Cruchet S, Obregon MC, Salazar G, et al.: Effect of the ingestion of a dietary product containing Lactobacillus johnsonii La1 on Helicobacter pylori colonization in children. Nutrition 2003, 19:716-721. This study suggests ingestion of selective probiotic bacteria may reduce infection rates with H. pylori with implications for the prevention of the leading cause of gastric cancer.
67. Anderson AD, McNaught CE, Jain PK, MacFie J: Randomised clinical trial of synbiotic therapy in elective surgical patients. Gut 2004, 53:241-245.
68. Dani C, Biadaioli R, Bertini G, et al.: Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 2002, 82:103-108.
69. Salminen MK, Rautelin H, Tynkkynen S, et al.: Lactobacillus bacteremia, clinical significance, and patient outcome, with special focus on probiotic L. rhamnosus GG. Clin Infect Dis 2004, 38:62-69 (Epub 2003 Dec 4).
70. Salminen MK, Tynkkynen S, Rautelin H, et al.: Lactobacillus bacteremia during a rapid increase in probiotic use of Lactobacillus rhamnosus GG in Finland. Clin Infect Dis 2002, 35:1155-1160 (Epub 2002 Oct 21).